Advertisement
ASTH vs EXETF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a Buy and EXETF is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ASTH’s FA Score shows that 0 FA rating(s) are green whileEXETF’s FA Score has 2 green FA rating(s).
- ASTH’s FA Score: 0 green, 5 red.
- EXETF’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ASTH’s TA Score shows that 5 TA indicator(s) are bullish while EXETF’s TA Score has 4 bullish TA indicator(s).
- ASTH’s TA Score: 5 bullish, 5 bearish.
- EXETF’s TA Score: 4 bullish, 5 bearish.
Price Growth
ASTH (@Hospital/Nursing Management) experienced а +4.54% price change this week, while EXETF (@Hospital/Nursing Management) price change was +0.51% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -1.79%. For the same industry, the average monthly price growth was +3.55%, and the average quarterly price growth was +6.10%.
Reported Earning Dates
ASTH is expected to report earnings on Oct 30, 2025.
EXETF is expected to report earnings on Nov 12, 2025.
Industries' Descriptions
@Hospital/Nursing Management (-1.79% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
| ASTH | EXETF | ASTH / EXETF | |
| Capitalization | 1.45B | 792M | 183% |
| EBITDA | 112M | 164M | 68% |
| Gain YTD | -0.634 | 30.757 | -2% |
| P/E Ratio | 61.46 | 13.58 | 453% |
| Revenue | 2.42B | 1.51B | 160% |
| Total Cash | 342M | 72.6M | 471% |
| Total Debt | 448M | 284M | 158% |
ASTH | EXETF | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 25 | 87 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | 8 Undervalued | |
PROFIT vs RISK RATING 1..100 | 86 | 25 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 42 | 50 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 10 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EXETF's Valuation (8) in the null industry is significantly better than the same rating for ASTH (78). This means that EXETF’s stock grew significantly faster than ASTH’s over the last 12 months.
EXETF's Profit vs Risk Rating (25) in the null industry is somewhat better than the same rating for ASTH (86). This means that EXETF’s stock grew somewhat faster than ASTH’s over the last 12 months.
EXETF's SMR Rating (100) in the null industry is in the same range as ASTH (100). This means that EXETF’s stock grew similarly to ASTH’s over the last 12 months.
ASTH's Price Growth Rating (42) in the null industry is in the same range as EXETF (50). This means that ASTH’s stock grew similarly to EXETF’s over the last 12 months.
ASTH's P/E Growth Rating (100) in the null industry is in the same range as EXETF (100). This means that ASTH’s stock grew similarly to EXETF’s over the last 12 months.
| ASTH | EXETF | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 70% | 2 days ago 50% |
| Stochastic ODDS (%) | 2 days ago 82% | 2 days ago 45% |
| Momentum ODDS (%) | 2 days ago 86% | 2 days ago 59% |
| MACD ODDS (%) | 2 days ago 82% | 2 days ago 53% |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 57% |
| TrendMonth ODDS (%) | 2 days ago 78% | 2 days ago 57% |
| Advances ODDS (%) | 2 days ago 79% | 17 days ago 58% |
| Declines ODDS (%) | 10 days ago 74% | 9 days ago 53% |
| BollingerBands ODDS (%) | 2 days ago 78% | 2 days ago 52% |
| Aroon ODDS (%) | 2 days ago 89% | 2 days ago 46% |
Advertisement
EXETF and
Correlation & Price change
A.I.dvisor tells us that EXETF and FSNUF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EXETF and FSNUF's prices will move in lockstep.
| Ticker / NAME | Correlation To EXETF | 1D Price Change % | ||
|---|---|---|---|---|
| EXETF | 100% | +0.55% | ||
| FSNUF - EXETF | 28% Poorly correlated | N/A | ||
| AIRS - EXETF | 27% Poorly correlated | +4.55% | ||
| INNV - EXETF | 23% Poorly correlated | -3.28% | ||
| ASTH - EXETF | 22% Poorly correlated | +0.38% | ||
| THC - EXETF | 22% Poorly correlated | +1.42% | ||
More | ||||